Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
Cheng-Yu YangChih-Kung LinCheng-Chih HsiehChang-Huei TsaoChun-Shu LinBo PengYen-Tzu ChenChun-Chieh TingWei-Chin ChangGu-Jiun LinHuey-Kang SytwuYuan-Wu ChenPublished in: Head & neck (2018)
TPL appeared to exert anticancer effects by repressing DcR3 and MTA1 in vitro, in vivo, and in PDTX models.